-
Modelling the Lymphatic Metastatic Progression Pathways of OPSCC from Multi-Institutional Datasets
Authors:
Roman Ludwig,
Adrian Schubert,
Dorothea Barbatei,
Lauence Bauwens,
Jean-Marc Hoffmann,
Sandrine Werlen,
Olgun Elicin,
Matthias Dettmer,
Philippe Zrounba,
Bertrand Pouymayou,
Panagiotis Balermpas,
Vincent Grégoire,
Roland Giger,
Jan Unkelbach
Abstract:
The elective clinical target volume (CTV-N) in oropharyngeal squamous cell carcinoma (OPSCC) is currently based mostly on the prevalence of lymph node metastases in different lymph node levels (LNLs) for a given primary tumor location. We present a probabilistic model for ipsilateral lymphatic spread that can quantify the microscopic nodal involvement risk based on an individual patient's T-catego…
▽ More
The elective clinical target volume (CTV-N) in oropharyngeal squamous cell carcinoma (OPSCC) is currently based mostly on the prevalence of lymph node metastases in different lymph node levels (LNLs) for a given primary tumor location. We present a probabilistic model for ipsilateral lymphatic spread that can quantify the microscopic nodal involvement risk based on an individual patient's T-category and clinical involvement of LNLs at diagnosis. We extend a previously published hidden Markov model (HMM), which models the LNLs (I, II, III, IV, V, and VII) as hidden binary random variables (RVs). Each represents a patient's true state of lymphatic involvement. Clinical involvement at diagnosis represents the observed binary RVs linked to the true state via sensitivity and specificity. The primary tumor and the hidden RVs are connected in a graph. Each edge represents the conditional probability of metastatic spread per abstract time-step, given disease at the edge's starting node. To learn these probabilities, we draw Markov chain Monte Carlo samples from the likelihood of a dataset (686 OPSCC patients) from three institutions. We compute the model evidence using thermodynamic integration for different graphs to determine which describes the data best. The graph maximizing the model evidence connects the tumor to each LNL and the LNLs I through V in order. It predicts the risk of occult disease in level IV is below 5% if level III is clinically negative, and that the risk of occult disease in level V is below 5% except for advanced T-category (T3 and T4) patients with clinical involvement of levels II, III, and IV. The provided statistical model of nodal involvement in OPSCC patients trained on multi-institutional data may guide the design of clinical trials on volume-deescalated treatment of OPSCC and contribute to more personal guidelines on elective nodal treatment.
△ Less
Submitted 21 December, 2023; v1 submitted 18 December, 2023;
originally announced December 2023.
-
Mathematical optimization of treatment schedules
Authors:
Bram L. Gorissen,
Jan Unkelbach,
Thomas R. Bortfeld
Abstract:
In the past decades mathematical optimization has found its way into radiation therapy and has made profound practice changing impact. Today, virtually all advanced treatment delivery methods, such as IMRT, VMAT, tomotherapy, LDR/HDR brachytherapy, proton therapy, are based on some form of optimization approach that changes the treatment variables (beam intensities, multileaf collimator shapes, be…
▽ More
In the past decades mathematical optimization has found its way into radiation therapy and has made profound practice changing impact. Today, virtually all advanced treatment delivery methods, such as IMRT, VMAT, tomotherapy, LDR/HDR brachytherapy, proton therapy, are based on some form of optimization approach that changes the treatment variables (beam intensities, multileaf collimator shapes, beam angles, dwell times and seed or source positions) in the planning computer using an optimization algorithm, until the best value of the treatment (planning) objective has been found. It is fair to say though that a truly optimal radiation treatment plan remains elusive. The reasons for that include difficulties in defining meaningful planning objectives and constraints in mathematical terms, various uncertainties in the planning and delivery process, and the inability of optimization algorithms to find the true optimum. Radiation therapy optimization therefore remains an active field of research.
△ Less
Submitted 30 October, 2018;
originally announced October 2018.
-
Optimization of spatiotemporally fractionated radiotherapy treatments with bounds on the achievable benefit
Authors:
Melissa R. Gaddy,
Sercan Yıldız,
Jan Unkelbach,
Dávid Papp
Abstract:
Spatiotemporal fractionation schemes, that is, treatments delivering different dose distributions in different fractions, may lower treatment side effects without compromising tumor control. This is achieved by hypofractionating parts of the tumor while delivering approximately uniformly fractionated doses to the healthy tissue. Optimization of such treatments is based on biologically effective do…
▽ More
Spatiotemporal fractionation schemes, that is, treatments delivering different dose distributions in different fractions, may lower treatment side effects without compromising tumor control. This is achieved by hypofractionating parts of the tumor while delivering approximately uniformly fractionated doses to the healthy tissue. Optimization of such treatments is based on biologically effective dose (BED), which leads to computationally challenging nonconvex optimization problems. Current optimization methods yield only locally optimal plans, and it has been unclear whether these are close to the global optimum. We present an optimization model to compute rigorous bounds on the normal tissue BED reduction achievable by such plans.
The approach is demonstrated on liver tumors, where the primary goal is to reduce mean liver BED without compromising other treatment objectives. First a uniformly fractionated reference plan is computed using convex optimization. Then a nonconvex quadratically constrained quadratic programming model is solved to local optimality to compute a spatiotemporally fractionated plan that minimizes mean liver BED subject to the constraints that the plan is no worse than the reference plan with respect to all other planning goals. Finally, we derive a convex relaxation of the second model in the form of a semidefinite programming problem, which provides a lower bound on the lowest achievable mean liver BED.
The method is presented on 5 cases with distinct geometries. The computed spatiotemporal plans achieve 12-35% mean liver BED reduction over the reference plans, which corresponds to 79-97% of the gap between the reference mean liver BEDs and our lower bounds. This indicates that spatiotemporal treatments can achieve substantial reduction in normal tissue BED, and that local optimization provides plans that are close to realizing the maximum potential benefit.
△ Less
Submitted 8 December, 2017;
originally announced December 2017.
-
A Mathematical Programming Approach to the Fractionation Problem in Chemoradiotherapy
Authors:
Ehsan Salari,
Jan Unkelbach,
Thomas Bortfeld
Abstract:
In concurrent chemoradiotherapy, chemotherapeutic agents are administered during the course of radiotherapy to enhance the primary tumor control. However, that often comes at the expense of increased risk of normal-tissue complications. The additional biological damage is mainly attributed to two mechanisms of action, which are the independent cytotoxic activity of chemotherapeutic agents and thei…
▽ More
In concurrent chemoradiotherapy, chemotherapeutic agents are administered during the course of radiotherapy to enhance the primary tumor control. However, that often comes at the expense of increased risk of normal-tissue complications. The additional biological damage is mainly attributed to two mechanisms of action, which are the independent cytotoxic activity of chemotherapeutic agents and their interactive cooperation with radiation. The goal of this study is to develop a mathematical framework to obtain drug and radiation administration schedules that maximize the therapeutic gain for concurrent chemoradiotherapy. In particular, we analyze the impact of incorporating these two mechanisms into the radiation fractionation problem. Considering each mechanism individually, we first derive closed-form expressions for the optimal radiation fractionation regimen and the corresponding drug administration schedule. We next study the case in which both mechanisms are simultaneously present and develop a dynamic programming framework to determine optimal treatment regimens. Results show that those chemotherapeutic agents that interact with radiation may change optimal radiation fractionation regimens. Moreover, administration of chemotherapeutic agents possessing both mechanisms may give rise to optimal non-stationary radiation fractionation schemes.
△ Less
Submitted 11 December, 2014; v1 submitted 19 December, 2013;
originally announced December 2013.
-
Optimization of Radiation Therapy Fractionation Schedules in the Presence of Tumor Repopulation
Authors:
Thomas Bortfeld,
Jagdish Ramakrishnan,
John N. Tsitsiklis,
Jan Unkelbach
Abstract:
We analyze the effect of tumor repopulation on optimal dose delivery in radiation therapy. We are primarily motivated by accelerated tumor repopulation towards the end of radiation treatment, which is believed to play a role in treatment failure for some tumor sites. A dynamic programming framework is developed to determine an optimal fractionation scheme based on a model of cell kill due to radia…
▽ More
We analyze the effect of tumor repopulation on optimal dose delivery in radiation therapy. We are primarily motivated by accelerated tumor repopulation towards the end of radiation treatment, which is believed to play a role in treatment failure for some tumor sites. A dynamic programming framework is developed to determine an optimal fractionation scheme based on a model of cell kill due to radiation and tumor growth in between treatment days. We find that faster tumor growth suggests shorter overall treatment duration. In addition, the presence of accelerated repopulation suggests larger dose fractions later in the treatment to compensate for the increased tumor proliferation. We prove that the optimal dose fractions are increasing over time. Numerical simulations indicate potential for improvement in treatment effectiveness.
△ Less
Submitted 24 April, 2015; v1 submitted 4 December, 2013;
originally announced December 2013.
-
Radiotherapy planning for glioblastoma based on a tumor growth model: Improving target volume delineation
Authors:
Jan Unkelbach,
Bjoern H. Menze,
Ender Konukoglu,
Florian Dittmann,
Matthieu Le,
Nicholas Ayache,
Helen A. Shih
Abstract:
Glioblastoma are known to infiltrate the brain parenchyma instead of forming a solid tumor mass with a defined boundary. Only the part of the tumor with high tumor cell density can be localized through imaging directly. In contrast, brain tissue infiltrated by tumor cells at low density appears normal on current imaging modalities. In clinical practice, a uniform margin is applied to account for m…
▽ More
Glioblastoma are known to infiltrate the brain parenchyma instead of forming a solid tumor mass with a defined boundary. Only the part of the tumor with high tumor cell density can be localized through imaging directly. In contrast, brain tissue infiltrated by tumor cells at low density appears normal on current imaging modalities. In clinical practice, a uniform margin is applied to account for microscopic spread of disease.
The current treatment planning procedure can potentially be improved by accounting for the anisotropy of tumor growth: Anatomical barriers such as the falx cerebri represent boundaries for migrating tumor cells. In addition, tumor cells primarily spread in white matter and infiltrate gray matter at lower rate. We investigate the use of a phenomenological tumor growth model for treatment planning. The model is based on the Fisher-Kolmogorov equation, which formalizes these growth characteristics and estimates the spatial distribution of tumor cells in normal appearing regions of the brain. The target volume for radiotherapy planning can be defined as an isoline of the simulated tumor cell density.
A retrospective study involving 10 glioblastoma patients has been performed. To illustrate the main findings of the study, a detailed case study is presented for a glioblastoma located close to the falx. In this situation, the falx represents a boundary for migrating tumor cells, whereas the corpus callosum provides a route for the tumor to spread to the contralateral hemisphere. We further discuss the sensitivity of the model with respect to the input parameters. Correct segmentation of the brain appears to be the most crucial model input.
We conclude that the tumor growth model provides a method to account for anisotropic growth patterns of glioblastoma, and may therefore provide a tool to make target delineation more objective and automated.
△ Less
Submitted 19 December, 2013; v1 submitted 22 November, 2013;
originally announced November 2013.
-
Exploiting tumor shrinkage through temporal optimization of radiotherapy
Authors:
Jan Unkelbach,
David Craft,
Theodore Hong,
David Papp,
Jagdish Ramakrishnan,
Ehsan Salari,
John Wolfgang,
Thomas Bortfeld
Abstract:
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which nor…
▽ More
In multi-stage radiotherapy, a patient is treated in several stages separated by weeks or months. This regimen has been motivated mostly by radiobiological considerations, but also provides an approach to reduce normal tissue dose by exploiting tumor shrinkage. The paper considers the optimal design of multi-stage treatments, motivated by the clinical management of large liver tumors for which normal liver dose constraints prohibit the administration of an ablative radiation dose in a single treatment.
We introduce a dynamic tumor model that incorporates three factors: radiation induced cell kill, tumor shrinkage, and tumor cell repopulation. The design of multi-stage radiotherapy is formulated as a mathematical optimization problem in which the total dose to the liver is minimized, subject to delivering the prescribed dose to the tumor. Based on the model, we gain insight into the optimal administration of radiation over time, i.e. the optimal treatment gaps and dose levels.
We analyze treatments consisting of two stages in detail. The analysis confirms the intuition that the second stage should be delivered just before the tumor size reaches a minimum and repopulation overcompensates shrinking. Furthermore, it was found that, for a large range of model parameters, approximately one third of the dose should be delivered in the first stage. The projected benefit of multi-stage treatments depends on model assumptions. However, the model predicts large liver dose reductions by more than a factor of two for plausible model parameters.
The analysis of the tumor model suggests that substantial reduction in normal tissue dose can be achieved by exploiting tumor shrinkage via an optimal design of multi-stage treatments. This suggests taking a fresh look at multi-stage radiotherapy for selected disease sites where substantial tumor regression translates into reduced target volumes.
△ Less
Submitted 9 May, 2014; v1 submitted 22 November, 2013;
originally announced November 2013.
-
Averaging VMAT treatment plans for multi-criteria navigation
Authors:
David Craft,
David Papp,
Jan Unkelbach
Abstract:
The main approach to smooth Pareto surface navigation for radiation therapy multi-criteria treatment planning involves taking real-time averages of pre-computed treatment plans. In fluence-based treatment planning, fluence maps themselves can be averaged, which leads to the dose distributions being averaged due to the linear relationship between fluence and dose. This works for fluence-based photo…
▽ More
The main approach to smooth Pareto surface navigation for radiation therapy multi-criteria treatment planning involves taking real-time averages of pre-computed treatment plans. In fluence-based treatment planning, fluence maps themselves can be averaged, which leads to the dose distributions being averaged due to the linear relationship between fluence and dose. This works for fluence-based photon plans and proton spot scanning plans. In this technical note, we show that two or more sliding window volumetric modulated arc therapy (VMAT) plans can be combined by averaging leaf positions in a certain way, and we demonstrate that the resulting dose distribution for the averaged plan is approximately the average of the dose distributions of the original plans. This leads to the ability to do Pareto surface navigation, i.e. interactive multi-criteria exploration of VMAT plan dosimetric tradeoffs.
△ Less
Submitted 31 January, 2014; v1 submitted 2 July, 2013;
originally announced July 2013.
-
Direct leaf trajectory optimization for volumetric modulated arc therapy planning with sliding window delivery
Authors:
Dávid Papp,
Jan Unkelbach
Abstract:
We propose a novel optimization model for volumetric modulated arc therapy (VMAT) planning that directly optimizes deliverable leaf trajectories in the treatment plan optimization problem, and eliminates the need for a separate arc-sequencing step. In this model, a 360-degree arc is divided into a given number of arc segments in which the leaves move unidirectionally. This facilitates an algorithm…
▽ More
We propose a novel optimization model for volumetric modulated arc therapy (VMAT) planning that directly optimizes deliverable leaf trajectories in the treatment plan optimization problem, and eliminates the need for a separate arc-sequencing step. In this model, a 360-degree arc is divided into a given number of arc segments in which the leaves move unidirectionally. This facilitates an algorithm that determines the optimal piecewise linear leaf trajectories for each arc segment, which are deliverable in a given treatment time. Multi-leaf collimator (MLC) constraints, including maximum leaf speed and interdigitation, are accounted for explicitly. The algorithm is customized to allow for VMAT delivery using constant gantry speed and dose rate, however, the algorithm generalizes to variable gantry speed if beneficial. We demonstrate the method for three different tumor sites: a head-and-neck case, a prostate case, and a paraspinal case. For that purpose, we first obtain a reference plan for intensity modulated radiotherapy (IMRT) using fluence map optimization and 20 equally spaced beam directions. Subsequently, VMAT plans are optimized by dividing the 360-degree arc into 20 corresponding arc segments. Assuming typical machine parameters (a dose rate of 600 MU/min, and a maximum leaf speed of 3 cm/sec), it is demonstrated that the quality of the optimized VMAT plans approaches the quality of the IMRT benchmark plan for delivery times between 3 and 4 minutes.
△ Less
Submitted 17 June, 2013;
originally announced June 2013.
-
Including robustness in multi-criteria optimization for intensity-modulated proton therapy
Authors:
Wei Chen,
Jan Unkelbach,
Alexei Trofimov,
Thomas Madden,
Hanne Kooy,
Thomas Bortfeld,
David Craft
Abstract:
We present a method to include robustness into a multi-criteria optimization (MCO) framework for intensity-modulated proton therapy (IMPT). The approach allows one to simultaneously explore the trade-off between different objectives as well as the trade-off between robustness and nominal plan quality. In MCO, a database of plans each emphasizing different treatment planning objectives, is pre-comp…
▽ More
We present a method to include robustness into a multi-criteria optimization (MCO) framework for intensity-modulated proton therapy (IMPT). The approach allows one to simultaneously explore the trade-off between different objectives as well as the trade-off between robustness and nominal plan quality. In MCO, a database of plans each emphasizing different treatment planning objectives, is pre-computed to approximate the Pareto surface. An IMPT treatment plan that strikes the best balance between the different objectives can be selected by navigating on the Pareto surface. In our approach, robustness is integrated into MCO by adding robustified objectives and constraints to the MCO problem. Uncertainties of the robust problem are modeled by pre-calculated dose-influence matrices for a nominal scenario and a number of pre-defined error scenarios. A robustified objective represents the worst objective function value that can be realized for any of the error scenarios. The optimization method is based on a linear projection solver and is capable of handling large problem sizes resulting from a fine dose grid resolution, many scenarios, and a large number of proton pencil beams. A base-of-skull case is used to demonstrate the robust optimization method. It is demonstrated that the robust optimizationmethod reduces the sensitivity of the treatment plan to setup and range errors to a degree that is not achieved by a safety margin approach. A chordoma case is analyzed in more detail to demonstrate the involved tradeoffs between target underdose and brainstem sparing as well as robustness and nominal plan quality. The latter illustrates the advantage of MCO in the context of robust planning. For all cases examined, the robust optimization for each Pareto optimal plan takes less than 5 min on a standard computer, making a computationally friendly interface possible to the planner.
△ Less
Submitted 22 December, 2011;
originally announced December 2011.
-
Time--delay autosynchronization of the spatio-temporal dynamics in resonant tunneling diodes
Authors:
J. Unkelbach,
A. Amann,
W. Just,
E. Schöll
Abstract:
The double barrier resonant tunneling diode exhibits complex spatio-temporal patterns including low-dimensional chaos when operated in an active external circuit. We demonstrate how autosynchronization by time--delayed feedback control can be used to select and stabilize specific current density patterns in a noninvasive way. We compare the efficiency of different control schemes involving feedb…
▽ More
The double barrier resonant tunneling diode exhibits complex spatio-temporal patterns including low-dimensional chaos when operated in an active external circuit. We demonstrate how autosynchronization by time--delayed feedback control can be used to select and stabilize specific current density patterns in a noninvasive way. We compare the efficiency of different control schemes involving feedback in either local spatial or global degrees of freedom. The numerically obtained Floquet exponents are explained by analytical results from linear stability analysis.
△ Less
Submitted 19 March, 2003;
originally announced March 2003.
